Nkarta (NKTX) Other Working Capital Changes (2022 - 2026)
Nkarta's (NKTX) quarterly Other Working Capital Changes came in at -$1.4 million in Q1 2026, down 4.26% year-on-year from -$1.5 million in Q1 2025, and down 3.5% quarter-over-quarter from -$1.4 million in Q4 2025.
Nkarta (NKTX) Other Working Capital Changes (2022 - 2026) Analysis & Trends
Nkarta's Other Working Capital Changes history runs 5 years deep, the most recent figure standing at -$1.4 million for Q1 2026.
- On a quarterly basis, Other Working Capital Changes fell 4.26% year-over-year to -$1.4 million in Q1 2026; TTM through Mar 2026 was -$5.1 million, a 23.36% increase from a year earlier, with the FY2025 full-year figure at -$5.0 million, up 21.9% from the prior year.
- Other Working Capital Changes eased to -$1.4 million in Q1 2026 per NKTX's latest filing, from -$1.4 million in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $4.9 million in Q3 2022 and bottomed at -$1.8 million in Q2 2022.
- The 5-year median for Other Working Capital Changes is -$430000.0 (2023), against an average of -$110176.5.
- Across the five-year window, Other Working Capital Changes surged 395.17% in 2023 and tumbled 1438.71% in 2025, its largest moves.
- Year by year, Other Working Capital Changes stood at $21.0 million in 2022, then plunged by 105.36% to -$1.1 million in 2023, then plunged by 161.72% to -$2.9 million in 2024, then soared by 53.44% to -$1.4 million in 2025, then slipped by 3.5% to -$1.4 million in 2026.
- Per Business Quant, the three latest NKTX Other Working Capital Changes figures stand at -$1.4 million (Q1 2026), -$1.4 million (Q4 2025), and -$1.9 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Nkarta | 170.79 Mn | 170.79 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.42 Mn |
| Mar 31, 2026 | -1.42 Mn |
| Mar 31, 2026 | -1.42 Mn |
| Dec 31, 2025 | -1.37 Mn |
| Dec 31, 2025 | -1.37 Mn |
| Dec 31, 2025 | -1.37 Mn |
| Sep 30, 2025 | -1.91 Mn |
| Sep 30, 2025 | -1.91 Mn |
| Sep 30, 2025 | -1.91 Mn |
| Jun 30, 2025 | -369,000.00 |
| Jun 30, 2025 | -369,000.00 |
| Jun 30, 2025 | -369,000.00 |
| Mar 31, 2025 | -1.36 Mn |
| Mar 31, 2025 | -1.36 Mn |
| Mar 31, 2025 | -1.36 Mn |
| Dec 31, 2024 | -2.95 Mn |
| Dec 31, 2024 | -2.95 Mn |
| Dec 31, 2024 | -2.95 Mn |
| Sep 30, 2024 | -124,000.00 |
| Sep 30, 2024 | -124,000.00 |